INSIGHTS ON PHARMACEUTICAL PACKAGING
-
Beyond The Instrument: How To Build A Defensible CCIT Method Selection Strategy
Selecting the right CCIT strategy starts with defining leakage risks and defect limits. Matching test methods to package design supports compliance, lifecycle needs, and patient safety.
-
Choosing The Right Pharma CMO: The 3 Cs That Matter Most
Choosing a CMO is a strategic decision that shapes long‑term quality and scalability. Discover how a focused framework helps teams identify partners that can adapt and support growing portfolios.
-
FAQs On The Revised EU GMP Annex 1: Volume 1
The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.
-
6 Strategic Pillars For Selecting A Drug Packaging Partner
Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.
-
Nebulizers: Package Integrity Testing Challenges And Solutions1/5/2026
Maintaining sterile packaging for nebulizer drugs is vital to prevent contamination. Learn how regulatory standards and advanced leak detection methods address integrity challenges in high-risk formats.
-
Clinical, Commercial Packaging: Delivering Next-Gen Therapies4/7/2026
See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
-
How To Save Significantly On Early-Phase Clinical Supply5/6/2026
Discover how integrated clinical supply strategies streamline early trials, reduce logistics complexity, cut costs, and ensure timely delivery of investigational products and samples.
-
Effective Procurement Strategies For Labeling Systems In Drug Manufacturing12/11/2024
What is actually behind the procurement of a pharmaceutical labeling machine and how does the process work? You can find out here what the path to your pharmaceutical labeling machine looks like.
-
Achieving EU GMP Annex 1 Compliance For Contamination Control3/4/2025
Gain insight into three areas that have been key in ensuring a robust contamination control strategy to help ensure compliance with the updated Annex 1 regulation: planning, people, and products.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
We are the exclusive manufacturing partner for this innovative auto-injector platform.
-
We provide a flexible and dynamic approach to GMP manufacturing. From first in human (FIH) through to phase 3 clinical supplies manufacturing at our MHRA Approved and Home Office Approved (I-IV) GMP facility, Trent Gateway.
-
Contract manufacturing and packaging services that bring your vision to market.
-
Our global capabilities span a scale of commercial packaging requirements from targeted therapies for select populations including biologics, through to large-scale projects requiring sophisticated technology integration. With true customer focus and flexibility at our core, we are able to adapt to the unique requirements of each global market need including brand and generic ethical pharmaceuticals, biotech medicines, over-the-counter pharmaceuticals, consumer healthcare products, specialized requirements for medical devices and specialty products.
-
The growing need for convenient and tamper-free packaging has proliferated the demand for blister packaging. Learn about contract blister packaging services that can produce several different packaging forms.